First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer

Conditions:   Advanced Solid Tumor;   Gastric Cancer;   Pancreas Cancer;   Gastroesophageal Junction Adenocarcinoma Intervention:   Drug: TORL-2-307-MAB Sponsors:   TORL Biotherapeutics, LLC;   Translational Research in Oncology Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials